Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group (Q34314320)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

author name string

R E George

1

1 reference

Europe PubMed Central

1 August 2017

S Variend

2

1 reference

Europe PubMed Central

1 August 2017

C Cullinane

3

1 reference

Europe PubMed Central

1 August 2017

S J Cotterill

4

1 reference

Europe PubMed Central

1 August 2017

A G McGuckin

5

1 reference

Europe PubMed Central

1 August 2017

C Ellershaw

6

1 reference

Europe PubMed Central

1 August 2017

J Lunec

7

1 reference

Europe PubMed Central

1 August 2017

A D Pearson

8

1 reference

Europe PubMed Central

1 August 2017

United Kingdom Children Cancer Study Group

9

1 reference

Europe PubMed Central

1 August 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

1 August 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

1 August 2017

36

1 reference

Europe PubMed Central

1 August 2017

1

1 reference

Europe PubMed Central

1 August 2017

169-176

1 reference

Europe PubMed Central

1 August 2017

Prognostic factor in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Observations on the histopathology of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Histologic patterns of neuroblastoma related to prognosis and clinical staging

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma)

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Evaluation of CD44 prognostic value in neuroblastoma: Comparison with the other prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

An analysis of neuroblastoma at a single institution

1 reference

https://api.crossref.org/works/10.1002%2F1096-911X%2820010101%2936%3A1%3C169%3A%3AAID-MPO1041%3E3.0.CO%3B2-U

21 January 2018

Identifiers

10.1002/1096-911X(20010101)36:1<169::AID-MPO1041>3.0.CO;2-U

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34314320&oldid=1546661725"